Standing O for Dr.Tim!!!
" The Company previously engaged the consulting firm Cote´ Orphan Consulting (COC), headed by Dr. Tim Cote´, to assist with the orphan drug application. Tim Cote´, MD, MPH, was the Director of the Office of Orphan Product Development (OOPD) at the FDA, from 2007 to 2011."